Transcription of the c-fos proto-oncogene is activated rapidly and transiently in many mammalian cell types treated with growth factors. In many cases, a specific sequence element in the c-fos promoter termed the Serum Response Element (SRE), is required. A nuclear factor, Serum Response Factor (SRF), which binds specifically to the SRE has been cloned. In order to understand how growth factors transmit their signals to the nucleus to rapidly activate new gene expression, SRFs mechanism of regulation will be studied in vivo and in vitro. While there is evidence that SRF is required for serum regulation of the fos gene, it is unknown how SRF is regulated. Biochemical approaches have not revealed a clear mechanism for SRF regulation. Therefore, SRF regulation will be studied using an in vivo assay we have developed to measure its function. A minimal regulatory domain of SRF required for regulation by growth factors has been identified and we will make further mutations to define critical elements of this region. This information will be critical for directing biochemical studies. An SRF-complexing protein, p62TCF, has been suggested to control SRF function. There is strong evidence, however, that it is not required and experiments are proposed to focus on the TCF- independent path way for SRF activation. Receptor tyrosine kinase mutants will also be used to distinguish cellular signalling pathways required for c-fos induction. Two putative inhibitory domains in SRF have been identified using GAL4-SRF constructs. These domains may be involved in regulation of SRF such that their functional significance will be further investigated. Methods are also proposed to identify SRF-complexing proteins that bind to regulatory domains defined above. Expression of c-fos is rapidly repressed after activation. The SRE has been shown to be sufficient for both activation and repression and fos protein production may cause the repression. The mechanism of repression will be investigated to determine whether SRF is involved and if so, which domains. Several methods are proposed to measure this activity and to separate SRF's activation and putative repression functions. The mechanism of transcriptional activation by SRF will be studied in vitro. This may help determine the critical functions of SRF regulated by serum. We have found that SRF interacts with TFIIF in vitro and propose that SRF activates transcription by recruiting TFIIF to the transcriptional initation complex. This SRF-TFIIF interaction will be further investigated to support this model.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA050329-05
Application #
2093708
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1989-07-01
Project End
1999-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Biology
Type
Other Domestic Higher Education
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Lewis, Thera C; Prywes, Ron (2013) Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochim Biophys Acta 1829:1147-59
Muehlich, S; Hampl, V; Khalid, S et al. (2012) The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1. Oncogene 31:3913-23
Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron (2010) Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 285:22036-49
Muehlich, Susanne; Wang, Ruigong; Lee, Seung-Min et al. (2008) Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Mol Cell Biol 28:6302-13
Shen, Jingshi; Snapp, Erik L; Lippincott-Schwartz, Jennifer et al. (2005) Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Mol Cell Biol 25:921-32
Selvaraj, Ahalya; Prywes, Ron (2004) Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol Biol 5:13
Shen, Jingshi; Prywes, Ron (2004) Dependence of site-2 protease cleavage of ATF6 on prior site-1 protease digestion is determined by the size of the luminal domain of ATF6. J Biol Chem 279:43046-51
Selvaraj, Ahalya; Prywes, Ron (2003) Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J Biol Chem 278:41977-87
Cen, Bo; Selvaraj, Ahalya; Burgess, Rebecca C et al. (2003) Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 23:6597-608
Chen, Xi; Shen, Jingshi; Prywes, Ron (2002) The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J Biol Chem 277:13045-52

Showing the most recent 10 out of 30 publications